MDM2 and MDMX inhibit the transcriptional activity of ectopically expressed SMAD proteins

Cancer Research

Volumn 59, Issue 20, 1999, Pages 5075-5078

  Yam, Cain H ^a   Siu, Wai Yi ^a   Arooz, Talha ^a   Chiu, Clarissa H S ^a   Lau, Anita ^a   Wang, Xiao Qi ^a   Poon, Randy Y C ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN MDM2; PROTEIN MDMX; PROTEIN P53; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; DNA-BINDING PROTEINS; HUMANS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RABBITS; SMAD4 PROTEIN; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0344995254     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Massague, J. TGF-β signal transduction. Annu. Rev. Biochem., 67: 753-791, 1998.
2. Lane, D. P., and Hall, P. A. MDM2: arbiter of p53's destruction. Trends Biochem. Sci., 22: 372-374, 1997.
3. Sun, P., Dong, P., Dai, K., Hannon, G. J., and Beach, D. p53-independem role of MDM2 inTGF-β1 resistance. Science (Washington DC), 282: 2270-2272, 1998.
4. Shvarts, A., Steegenga, W. T., Riteco, N., van Laar, T., Dekker, P., Bazuine, M., van Ham, R. C., van der Houven van Oordt, W., Hateboer, G., van der Eb, A. J., and Jochemsen, A. G. MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J., 15: 5349-5357, 1996.
5. wafl expression and growth inhibition in human carcinoma cells. Cancer Res., 58: 5656-5661, 1998.
6. Yam, C. H., Ng, R. W. M., Siu, W. Y., Lau, A. W. S., and Poon, R. Y. C. Regulation of cyclin A-Cdk2 by SCF component Skpl and F-box protein Skp2. Mol. Cell. Biol., 19: 635-645, 1999.
7. Chen, Y., Lebrun, J-J., and Vale, W. Regulation of transforming growth factor- and activin-induced transcription by mammalian Mad proteins. Proc. Natl. Acad. Sci. USA, 93: 12992-12997, 1996.
8. Gossen, M., and Bujard, H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA, 89: 5547-5551, 1992.
9. Ausubel, F., Brent, R., Kingston, R., Moore, D., Seidman, J., Smith, J., and Struhl, K. Current Protocols in Molecular Biology. New York: John Wiley and Sons, 1991.
10. Poon, R. Y. C., Toyoshima, H., and Hunter, T. Redistribution of the CDK inhibitor p27 between different cyclin-CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or UV irradiation. Mol. Biol. Cell, 6: 1197-1213, 1995.
11. 160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin. Science (Washington DC), 270: 90-93, 1995.
12. Poon, R. Y. C., Jiang, W., Toyoshima, H., and Hunter, T. Cyclin-dependent kinases are inactivated by a combination of p21 and Thr14/Tyr15 phosphorylation after UV-induced DNA damage. J. Biol. Chem., 271: 13283-13291, 1996.
13. Zeng, X., Chen, L., Jost, C. A., Maya, R., Keller, D., Wang, X., Kaelin, W. G. J., Oren, M., Chen, J., and Lu. H. MDM2 suppresses p73 function without promoting p73 degradation. Mol. Cell. Biol.. 19: 3257-3266, 1999.
14. Dobbelstein, M., Wienzek, S., Kašnig, C., and Roth, J. Inactivation of the p53-homologue p73 by the mdm2-oncoprotein. Oncogene, 18: 2101-2106, 1999.
15. Ongkeko, W. M., Wang, X. Q., Siu, W. Y., Lau, A. W. S., Yamashita, K., Harris, A. L., Cox, L. S., and Poon, R. Y. C. MDM2 and MDMX target p53 for degradation but stabilize p73. Curr. Biol., 9: 829-832, 1999.
16. Kubbutat, M. H., Jones, S. N., and Vousden, K. H. Regulation of p53 stability by Mdm2. Nature (Lond.), 387: 299-303, 1997.
17. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. Mdm2 promotes the rapid degradation of p53. Nature (Lond.), 387: 296-299, 1997.